Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 926962, 9 pages
http://dx.doi.org/10.1155/2014/926962
Research Article

Circulating MicroRNA Profiles Differ between Qi-Stagnation and Qi-Deficiency in Coronary Heart Disease Patients with Blood Stasis Syndrome

1Xiyuan Hospital of China Academy of Chinese Medical Sciences, 1 Xiyuan Caochang, Haidian District, Beijing 100091, China
2Beijing Key Laboratory of Pharmacology of Chinese Materia Medica, Institute of Basic Medical Sciences of Xiyuan Hospital, 1 Xiyuan Caochang, Haidian District, Beijing 100091, China
3Institute of Basic Theory, China Academy of Chinese Medical Sciences, 16 Dong Zhi Men Nei Nan Xiao Jie, Beijing 100700, China

Received 14 August 2014; Accepted 6 November 2014; Published 4 December 2014

Academic Editor: Karl Wah-Keung Tsim

Copyright © 2014 Jincai Hou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. S. Lim, T. Vos, A. D. Flaxman et al., “A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010,” The Lancet, vol. 380, no. 9859, pp. 2224–2260, 2012. View at Google Scholar
  2. C. J. L. Murray and A. D. Lopez, “Measuring the global burden of disease,” The New England Journal of Medicine, vol. 369, no. 5, pp. 448–457, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Lu and K. Chen, “Chinese medicine pattern diagnosis could lead to innovation in medical sciences,” Journal of Traditional Chinese Medicine, vol. 17, no. 11, pp. 811–817, 2011. View at Google Scholar
  4. M. Jiang, C. Lu, C. Zhang et al., “Syndrome differentiation in modern research of traditional Chinese medicine,” Journal of Ethnopharmacology, vol. 140, no. 3, pp. 634–642, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Xing, J. Wang, X. Yang et al., “The effects of Xuefu Zhuyu and Shengmai on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris after percutaneous coronary intervention: a randomised controlled clinical trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 896467, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. R. C. Friedman, K. K.-H. Farh, C. B. Burge, and D. P. Bartel, “Most mammalian mRNAs are conserved targets of microRNAs,” Genome Research, vol. 19, no. 1, pp. 92–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Small and E. N. Olson, “Pervasive roles of microRNAs in cardiovascular biology,” Nature, vol. 469, no. 7330, pp. 336–342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Fichtlscherer, A. M. Zeiher, and S. Dimmeler, “Circulating MicroRNAs: biomarkers or mediators of cardiovascular diseases?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 11, pp. 2383–2390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Q. Li, C. Chen, M. D. Xu et al., “The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats,” The FEBS Journal, vol. 278, no. 9, pp. 1522–1532, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Jiang, X. Liang, Y. Chen et al., “Integrating next-generation sequencing and traditional tongue diagnosis to determine tongue coating microbiome,” Scientific Reports, vol. 2, p. 936, 2012. View at Google Scholar
  11. W. Yao, H. Yang, and G. Ding, “Mechanisms of Qi-blood circulation and Qi deficiency syndrome in view of blood and interstitial fluid circulation,” Journal of Traditional Chinese Medicine, vol. 33, no. 4, pp. 538–544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Jiang, C. Zhang, H. Cao, K. Chan, and A. Lu, “The role of Chinese medicine in the treatment of chronic diseases in China,” Planta Medica, vol. 77, no. 9, pp. 873–881, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. K. Yoo, H. Y. Jung, C.-H. Kim, W. S. Son, and J. K. Kim, “MiR-7641 modulates the expression of CXCL1 during endothelial differentiation derived from human embryonic stem cells,” Archives of Pharmacal Research, vol. 36, no. 3, pp. 353–358, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Das, S. Saikolappan, and S. Dhandayuthapani, “Differential expression of miRNAs by macrophages infected with virulent and avirulent Mycobacterium tuberculosis,” Tuberculosis, vol. 93, pp. S47–S50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Cheng, S. Qiu, L. Jiang et al., “MiR-320a is downregulated in patients with Myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1,” Journal of Clinical Immunology, vol. 33, no. 3, pp. 567–576, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Mousa, “Cell adhesion molecules: potential therapeutic & diagnostic implications,” Molecular Biotechnology, vol. 38, no. 1, pp. 33–40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Oh and J.-H. Park, “Endocytosis and exocytosis of nanoparticles in mammalian cells,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 51–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. C. N. Antonescu, T. E. McGraw, and A. Klip, “Reciprocal regulation of endocytosis and metabolism,” Cold Spring Harbor Perspectives in Biology, vol. 6, no. 7, Article ID a016964, 2014. View at Publisher · View at Google Scholar
  19. M. Khaidakov, F. Mercanti, X. Wang et al., “Prevention of export of anoxia/ reoxygenation injury from ischemic to nonischemic cardiomyocytes via inhibition of endocytosis,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 306, no. 12, pp. H1700–H1707, 2014. View at Google Scholar
  20. A. J. Meijer and P. Codogno, “Signalling and autophagy regulation in health, aging and disease,” Molecular Aspects of Medicine, vol. 27, no. 5-6, pp. 411–425, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Kang, H. J. Zeh, M. T. Lotze, and D. Tang, “The Beclin 1 network regulates autophagy and apoptosis,” Cell Death & Differentiation, vol. 18, no. 4, pp. 571–580, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Yu, C. K. McPhee, L. Zheng et al., “Termination of autophagy and reformation of lysosomes regulated by Mtor,” Nature, vol. 465, no. 7300, pp. 942–946, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Aki, K. Yamaguchi, T. Fujimiya, and Y. Mizukami, “Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the rat cardiomyocyte-derived cell line H9c2,” Oncogene, vol. 22, no. 52, pp. 8529–8535, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Valentim, K. M. Laurence, P. A. Townsend et al., “Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury,” Journal of Molecular and Cellular Cardiology, vol. 40, no. 6, pp. 846–852, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. X.-P. Ren, J. Wu, X. Wang et al., “MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20,” Circulation, vol. 119, no. 17, pp. 2357–2366, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Feng and S. Chakrabarti, “MiR-320 regulates glucose-induced gene expression in diabetes,” ISRN Endocrinology, vol. 2012, Article ID 549875, 6 pages, 2012. View at Publisher · View at Google Scholar